Trade Name: Topmega
Generic Name: Oprelvekin (Recombinant Human Interleukin 11, rHuIL-11)
Brief Introduction:
1. National Medical Insurance, Category B.
2. Launched in 2005.
3. National standard bulk supplier of rHuIL-11.
4. Participated in the development and collaborative calibration of rHuIL-11 national reference standards.
Indications:
Severe thrombocytopenia with degree III and IV induced by chemotherapy to solid tumor and to non-marrow leukemia.
Strengths:
1mg/vial, 1.5mg/vial, 2mg/vial, 3mg/vial, 5mg/vial
Product description download：Oprelvekin.pdf
Academic progress
Tel：86 592 6889105/108
Email： bd.amoytop@gmail.com / international@amoytop.com
Add：No. 330 Wengjiao Road, Haicang, Xiamen, Fujian, China
Join Us：0592-7701210
Email：hr@amoytop.com
Adverse Events Tel：86-592-6889111
Adverse Events Email：fk@amoytop.com
